Topics:
Radiation Oncology • Gastrointestinal Cancers • Stereotactic Body Radiotherapy • Medical Oncology • Liver and Pancreas Tumors
When is SBRT or hypofractionated radiation appropriate as adjuvant treatment for pancreatic cancer?
What are the targets (tumor bed, positive margin, nodes etc.)?
Answer from: Radiation Oncologist at Community Practice
As @Christopher H. Crane outlines above, the management of resected pancreatic cancer is controversial and a “standard” adjuvant treatment approach has yet to be determined. We patiently await the results of RTOG 0848, the current cooperative group trial evaluating the role of conve...
Comments
Radiation Oncologist at Washington University School of Medicine
To make sure I understand the target volumes corre...
To make sure I understand the target volumes corre...
Medical Oncologist at Siri Onclogy and hematology Infusion Service
most would accept that FOLFIRINOX or modified FOLF...
most would accept that FOLFIRINOX or modified FOLF...
Answer from: Radiation Oncologist at Community Practice
In response to your questions:
1) Yes, the afferent limb is treated as an avoidance structure (organ at risk-OAR). We contour all anastomoses (HJ, PJ, and GJ), jejunum, small bowel (excluding the jejunum), and stomach as OARs.
-The&...
Answer from: Radiation Oncologist at Community Practice
Hypo will result in damage to surrounding tissues/organs if the patient lives >1 year, If expected survival is 1 year or less (as is typical for Pancreatic ca), then hypofractionated RT is fine
Comments
Radiation Oncologist at Memorial Sloan-Kettering Cancer Center
Based on what data?
Based on what data?
please, could we have the reference to 5-year dise...